Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_8b919a09598a02c07e8429b1441b76e1 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C201-16 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C201-12 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C205-56 |
filingDate |
1985-10-03-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
grantDate |
1987-12-01-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8e56a479e6a20bf4e3c747afb1917674 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ede78182b3377d3775195a94c77e1573 |
publicationDate |
1987-12-01-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
US-4710581-A |
titleOfInvention |
Nucleophilic substitution process |
abstract |
Halonitroarylacetic acid esters are prepared by reacting a halonitroaromatic compound with an alpha,alpha-disubstituted acetic acid ester in an inert solvent and in the presence of a base. The halonitroarylacetic acid esters formed by the process can be readily converted into derivatives, such as pharmaceuticals. |
isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5166431-A |
priorityDate |
1981-10-16-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |